XML 44 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
REVERSE MERGER (Narratives) (Details) - USD ($)
1 Months Ended 6 Months Ended
Jun. 29, 2017
Mar. 31, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Business Combination Segment Allocation [Line Items]          
Shares converted, value $ 3,000,000   $ 0 $ 433,000  
Common stock, shares outstanding (in shares)     6,407,860   449,175
Preferred stock, dividend rate (percentage)   8.00%      
Convertible Debt          
Business Combination Segment Allocation [Line Items]          
Debt instrument, face amount 800,000        
Private Placement          
Business Combination Segment Allocation [Line Items]          
Consideration received 400,000        
Transgenomics          
Business Combination Segment Allocation [Line Items]          
Conversion of convertible promissory notes to equity $ 3,000,000        
Sale of stock, price per share $ 6.80        
Common stock, shares outstanding (in shares) 895,334        
Preferred stock, dividend rate (percentage) 8.00%        
Common Stock          
Business Combination Segment Allocation [Line Items]          
Number of shares converted, shares 4,317,152        
New shares issued (in shares) 200,081        
Common Stock | Precipio Diagnostic          
Business Combination Segment Allocation [Line Items]          
Number of shares converted, shares 5,352,847        
Common Stock | Transgenomics          
Business Combination Segment Allocation [Line Items]          
Number of shares converted from debt instrument (shares) 352,630        
Preferred Stock          
Business Combination Segment Allocation [Line Items]          
Number of shares converted from debt instrument (shares) 802,920        
Share price (in dollars per share) $ 12.20        
Preferred Stock | Private Placement          
Business Combination Segment Allocation [Line Items]          
New shares issued (in shares) 107,056        
Preferred Stock | Transgenomics          
Business Combination Segment Allocation [Line Items]          
Number of shares converted, shares 7,155        
Number of shares converted from debt instrument (shares) 802,925